CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Commercial Officer sold 2,902 shares at $22.32 ($64,773)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Financial Officer sold 2,179 shares at $24.79 ($54,017)
- 4 Open-market sale Chief Legal Officer sold 6,395 shares at $26.28 ($168,061)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Open-market sale Director sold 25,000 shares at $25.96 ($648,888)
- 4 Planned sale Chief Executive Officer sold 10,178 shares at $25.48 ($259,335)
- 4 Open-market sale Principal Accounting Officer sold 2,918 shares at $25.39 ($74,096)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Principal Accounting Officer sold 1,232 shares at $26.26 ($32,352)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal Officer sold 1,707 shares at $28.36 ($48,411)
- 4 Planned sale Director sold 10,718 shares at $28.36 ($303,962)
- 4 Planned sale Chief Medical Officer sold 1,707 shares at $28.36 ($48,411)
- 4 Planned sale Chief Executive Officer sold 11,449 shares at $28.36 ($324,694)
Page 15 of 66 · 1,304 filings